-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's exclusive distribution of injectable type A botulinum toxin products produced by South Korea's Huons BP in China has obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration.

Zhitongcaijing·01/08/2026 12:17:07
Listen to the news
Zhitong Finance App News, Aimeike (300896.SZ) announced that the company's exclusive distribution of injectable type A botulinum toxin products produced by South Korea's Huons BP in China has obtained the “Drug Registration Certificate” approved and issued by the State Drug Administration.